GLP-1 receptor agonist medications (including semaglutide, dulaglutide, liraglutide, exenatide, and lixisenatide) are typically considered for type 2 diabetes when: Triple therapy with other diabetes medications is not effective, not tolerated, or contraindicated The person has a BMI 35 kg/m (adjusted by 2.5 kg/m for people from South Asian, Chinese, other Asian, Black African, or African-Caribbean backgrounds) and specific weight-related psychological or medical problems A lower BMI threshold may be appropriate if weight loss would benefit other obesity-related comorbidities Insulin would not be appropriate or acceptable to the person Treatment is usually continued only if there is a beneficial metabolic response (reduction in HbA1c and weight) after 6 months
Thats one reason lighter foods like wraps, salads, smoothies, and bowls can work especially well this time of year
New England Journal of Medicine, 384 (11), 989-1002
The program also includes supplemental medications when clinically appropriate, such as metformin, phentermine, or nausea medication, along with injection supplies and medication shipping for added convenience
For more significant progress, consider splurging on a new workout outfit or indulging in a professional massage
